Company intelligence / Profile preview

Wuhan Dingxintong Pharmaceutical

Wuhan, Hubei, China

Ownership: Private
Development stage: Other

Overview

Wuhan Dingxintong Pharmaceutical is a China-based pharmaceutical manufacturer and supplier, active in the production and supply of active pharmaceutical ingredients (APIs) including remdesivir, tilmicosin phosphate, and tildipirosin. The company primarily serves the global market as a supplier of APIs used in anti-infective and possibly veterinary and human health indications. There is no evidence of proprietary clinical R&D or branded drug development.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Wuhan Dingxintong Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Dingxintong Pharmaceutical.

Explore the full profile